tiprankstipranks
Trending News
More News >
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
US Market

Aspen Pharmacare (APNHY) Ratios

Compare
22 Followers

Aspen Pharmacare Ratios

APNHY's free cash flow for Q4 2023 was Rs0.43. For the 2023 fiscal year, APNHY's free cash flow was decreased by Rs and operating cash flow was Rs0.23. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
1.81 1.81 1.92 1.48 0.89
Quick Ratio
1.07 1.07 1.08 0.80 0.53
Cash Ratio
0.51 0.51 0.47 0.26 0.23
Solvency Ratio
0.11 0.12 0.15 0.20 0.15
Operating Cash Flow Ratio
0.26 0.26 0.24 0.23 0.19
Short-Term Operating Cash Flow Coverage
0.56 0.56 0.71 0.47 0.28
Net Current Asset Value
Rs -10.21BRs -10.21BRs -3.55BRs -5.87BRs -11.35B
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.26 0.22 0.20 0.23
Debt-to-Equity Ratio
0.43 0.43 0.34 0.31 0.38
Debt-to-Capital Ratio
0.30 0.30 0.25 0.24 0.27
Long-Term Debt-to-Capital Ratio
0.23 0.23 0.20 0.13 0.00
Financial Leverage Ratio
1.64 1.64 1.56 1.57 1.67
Debt Service Coverage Ratio
0.75 0.65 0.90 0.72 0.29
Interest Coverage Ratio
7.30 3.14 5.91 11.33 5.87
Debt to Market Cap
0.46 0.36 0.36 0.33 0.33
Interest Debt Per Share
84.24 87.08 68.90 50.80 57.13
Net Debt to EBITDA
2.34 2.44 1.93 1.53 1.88
Profitability Margins
Gross Profit Margin
43.43%43.43%45.22%47.42%47.10%
EBIT Margin
19.89%17.76%19.35%23.05%18.61%
EBITDA Margin
23.04%22.16%23.34%27.16%22.95%
Operating Profit Margin
15.65%15.65%19.21%22.46%18.73%
Pretax Profit Margin
12.78%12.78%16.10%21.07%15.86%
Net Profit Margin
9.85%9.85%12.84%16.81%12.73%
Continuous Operations Profit Margin
9.85%9.85%12.84%16.81%12.70%
Net Income Per EBT
77.07%77.07%79.76%79.76%80.25%
EBT Per EBIT
81.65%81.65%83.80%93.81%84.69%
Return on Assets (ROA)
3.16%3.16%3.89%5.83%4.38%
Return on Equity (ROE)
5.17%5.19%6.06%9.15%7.32%
Return on Capital Employed (ROCE)
6.10%6.10%7.04%9.86%9.70%
Return on Invested Capital (ROIC)
4.28%4.28%5.24%6.94%5.81%
Return on Tangible Assets
6.54%6.54%7.97%12.31%9.58%
Earnings Yield
5.60%4.40%6.41%9.80%6.48%
Efficiency Ratios
Receivables Turnover
4.34 4.34 4.04 4.68 3.62
Payables Turnover
5.78 5.78 5.62 5.58 6.06
Inventory Turnover
1.40 1.40 1.14 1.29 1.49
Fixed Asset Turnover
2.18 2.18 2.15 2.38 2.48
Asset Turnover
0.32 0.32 0.30 0.35 0.34
Working Capital Turnover Ratio
2.19 2.18 2.50 10.84 5.17
Cash Conversion Cycle
280.80 280.80 346.37 295.89 285.63
Days of Sales Outstanding
84.09 84.09 90.44 77.93 100.87
Days of Inventory Outstanding
259.82 259.82 320.89 283.42 245.00
Days of Payables Outstanding
63.10 63.10 64.96 65.47 60.24
Operating Cycle
343.90 343.90 411.33 361.36 345.87
Cash Flow Ratios
Operating Cash Flow Per Share
14.02 14.01 12.43 11.86 14.95
Free Cash Flow Per Share
7.00 1.55 5.27 5.91 7.43
CapEx Per Share
7.02 12.46 7.16 5.95 7.52
Free Cash Flow to Operating Cash Flow
0.50 0.11 0.42 0.50 0.50
Dividend Paid and CapEx Coverage Ratio
1.34 0.88 1.19 1.38 1.99
Capital Expenditure Coverage Ratio
2.00 1.12 1.74 1.99 1.99
Operating Cash Flow Coverage Ratio
0.17 0.17 0.19 0.24 0.27
Operating Cash Flow to Sales Ratio
0.14 0.14 0.14 0.14 0.18
Free Cash Flow Yield
3.95%0.69%2.87%4.04%4.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.85 22.73 15.61 10.21 15.43
Price-to-Sales (P/S) Ratio
1.76 2.24 2.01 1.72 1.96
Price-to-Book (P/B) Ratio
0.93 1.18 0.95 0.93 1.13
Price-to-Free Cash Flow (P/FCF) Ratio
25.30 145.09 34.90 24.74 21.85
Price-to-Operating Cash Flow Ratio
12.63 16.08 14.79 12.32 10.87
Price-to-Earnings Growth (PEG) Ratio
-1.88 -1.44 -0.88 0.21 -1.68
Price-to-Fair Value
0.93 1.18 0.95 0.93 1.13
Enterprise Value Multiple
9.97 12.54 10.52 7.85 10.44
Enterprise Value
EV to EBITDA
9.97 12.54 10.52 7.85 10.44
EV to Sales
2.30 2.78 2.46 2.13 2.40
EV to Free Cash Flow
33.06 180.04 42.75 30.74 26.66
EV to Operating Cash Flow
16.50 19.96 18.11 15.31 13.26
Tangible Book Value Per Share
29.38 29.37 39.48 27.12 13.42
Shareholders’ Equity Per Share
191.07 191.04 194.14 156.60 143.76
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.20 0.20 0.20
Revenue Per Share
100.66 100.64 91.65 85.22 82.73
Net Income Per Share
9.92 9.91 11.77 14.32 10.53
Tax Burden
0.77 0.77 0.80 0.80 0.80
Interest Burden
0.64 0.72 0.83 0.91 0.85
Research & Development to Revenue
<0.01 <0.01 <0.01 0.01 <0.01
SG&A to Revenue
0.08 0.08 0.04 0.04 0.05
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.41 0.89 0.71 0.62 1.03
Currency in ZAR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis